Advertisement

Topics

Advancis Pharmaceutical Corp Company Profile

02:21 EDT 19th June 2018 | BioPortfolio

Advancis™ is a forward-thinking company built on a foundation of extensive pharmaceutical knowledge. Founded in 1999, Advancis has discovered a novel biological finding with the potential to fundamentally advance the way we fight bacteria. Our mission, based on this proprietary discovery, is to develop and commercialize value-added pharmaceuticals for the anti-infectives market

Location

20425 Seneca Meadows Parkway
Germantown
20876
United States of America

Contact

Phone: 301-944-6600
Fax: 301-944-6700
Email: bd@advancispharm.com


News Articles [327 Associated News Articles listed on BioPortfolio]

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced toda...

GTX Corp First Quarter 2018 Summary

Revenues increased 76%, Subscribers increased 79%, G&A decreased 17% LOS ANGELES, May 16, 2018 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB:GTXO), an IoT platform and leading provider of personal loc...

Emblem Corp. Reports 2018 First Quarter Results

Strengthened team, new products, and key distribution partnerships driving demand NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 2...

Emblem Corp. Issues President’s Letter to Shareholders

TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) ("Emblem" or the "Corporation") provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ...

GTX Corp and Veristride Presenting Biometric Insoles at CES 2018

LOS ANGELES, Jan. 04, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business...

Scythian Biosciences Corp. Announces Upgrade to the OTCQB Marketplace

TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has been upgraded...

Scythian Biosciences Announces Name Change to SOL Global Investments Corp.

TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Compa...

PubMed Articles [460 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical cocrystals as an opportunity to modify drug properties: From the idea to application. A review.

The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...

Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.

This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.

Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.

The non-medical use (NMU) of pharmaceutical drugs is an increasing public health concern. This systematic review consolidates current knowledge about how pharmaceutical drugs are obtained for NMU and ...

Clinical Trials [301 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Companies [1070 Associated Companies listed on BioPortfolio]

Advancis Pharmaceutical Corp

Advancis™ is a forward-thinking company built on a foundation of extensive pharmaceutical knowledge. Founded in 1999, Advancis has discovered a novel biological finding with the potential to fundame...

ATLANTIS DRUG CORP

Nil

NORLOFF COMPUTER CORP

Nil

Precision Engineered Products LLC

SINOCHEM JIANGSU SUZHOU I/E CORP.

SINOCHEM JIANGSU SUZHOU I/E CORP. ESTABLISHED IN 1988, IS A SUBSIDIARY OF SINOCHEM AND A STATE-OWNED FOREIGH TRADE ENTERPRISE AUTHORISED BY THE CHINESE MINISTRY OF FOREIGH TRADE AND ECONOMIC C...

More Information about "Advancis Pharmaceutical Corp" on BioPortfolio

We have published hundreds of Advancis Pharmaceutical Corp news stories on BioPortfolio along with dozens of Advancis Pharmaceutical Corp Clinical Trials and PubMed Articles about Advancis Pharmaceutical Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advancis Pharmaceutical Corp Companies in our database. You can also find out about relevant Advancis Pharmaceutical Corp Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record